A detailed history of Lincoln National Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lincoln National Corp holds 13,959 shares of EW stock, worth $1.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,959
Previous 14,065 0.75%
Holding current value
$1.28 Million
Previous $1.07 Million 24.35%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$72.54 - $95.56 $7,689 - $10,129
-106 Reduced 0.75%
13,959 $1.33 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $10,428 - $13,141
-169 Reduced 1.19%
14,065 $1.07 Million
Q3 2023

Nov 03, 2023

SELL
$69.28 - $93.38 $187,194 - $252,312
-2,702 Reduced 15.95%
14,234 $986,000
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $67,733 - $78,482
-832 Reduced 4.68%
16,936 $1.6 Million
Q1 2023

May 01, 2023

SELL
$74.26 - $84.51 $933,596 - $1.06 Million
-12,572 Reduced 41.44%
17,768 $1.47 Million
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $247,041 - $316,270
3,617 Added 13.54%
30,340 $2.26 Million
Q3 2022

Nov 03, 2022

BUY
$82.37 - $107.29 $91,595 - $119,306
1,112 Added 4.34%
26,723 $2.21 Million
Q2 2022

Aug 02, 2022

BUY
$86.5 - $128.27 $10,120 - $15,007
117 Added 0.46%
25,611 $2.44 Million
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $45,576 - $57,367
-447 Reduced 1.72%
25,494 $3 Million
Q4 2021

Jan 26, 2022

SELL
$106.37 - $130.68 $52,546 - $64,555
-494 Reduced 1.87%
25,941 $3.36 Million
Q3 2021

Nov 05, 2021

BUY
$102.91 - $122.75 $62,157 - $74,141
604 Added 2.34%
26,435 $2.99 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $204,401 - $255,404
2,438 Added 10.42%
25,831 $2.68 Million
Q1 2021

May 10, 2021

SELL
$78.68 - $90.67 $217,550 - $250,702
-2,765 Reduced 10.57%
23,393 $1.96 Million
Q4 2020

Feb 05, 2021

BUY
$71.69 - $91.23 $98,000 - $124,711
1,367 Added 5.51%
26,158 $2.39 Million
Q3 2020

Nov 09, 2020

BUY
$67.19 - $87.44 $116,977 - $152,233
1,741 Added 7.55%
24,791 $1.98 Million
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $892,733 - $1.19 Million
15,515 Added 205.91%
23,050 $1.59 Million
Q1 2020

Apr 24, 2020

BUY
$52.41 - $81.0 $50,103 - $77,436
956 Added 14.53%
7,535 $1.42 Million
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $155,947 - $178,545
2,175 Added 49.39%
6,579 $1.54 Million
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $9,294 - $11,389
151 Added 3.55%
4,404 $969,000
Q2 2019

Aug 06, 2019

BUY
$55.74 - $64.41 $237,062 - $273,935
4,253 New
4,253 $786,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $121,113 - $161,982
-2,529 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$46.41 - $56.94 $32,069 - $39,345
691 Added 37.6%
2,529 $387,000
Q3 2018

Nov 06, 2018

BUY
$45.7 - $58.03 $2,559 - $3,249
56 Added 3.14%
1,838 $320,000
Q2 2018

Aug 08, 2018

BUY
$42.45 - $51.3 $8,362 - $10,106
197 Added 12.43%
1,782 $259,000
Q1 2018

May 09, 2018

SELL
$37.19 - $47.45 $45,483 - $58,031
-1,223 Reduced 43.55%
1,585 $221,000
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $94,882 - $110,607
2,808
2,808 $316,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.